Patient Care

Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and…

1 year ago

OrthoNebraska Selects Health Catalyst Ignite™ to Advance Data-Driven Orthopedic Care

SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and…

1 year ago

New Standard for Medtech Alternate Equipment Management (AEM)

AAMI Document Clarifies Repair RequirementsArlington, VA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Alternate equipment management (AEM) plans for medical devices…

1 year ago

Universal Brain Announces Publication of Groundbreaking Depression Research Using Multiple Event-Related Potentials

New findings support the company's neuroscience-driven approach to precision psychiatry, offering actionable insights for personalized depression treatment PALO ALTO, Calif.,…

1 year ago

VSee Health Secures Major Contract with Leading Florida Health System to Deliver Home Health and TeleNursing

Driving Healthcare Innovation and Growth Across Hospitals and CommunitiesSAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE), a leader in comprehensive…

1 year ago

PharmD On Demand + 340B

Unlocking Significant Savings for Rural Hospitals WATKINSVILLE, GA / ACCESSWIRE / January 10, 2025 / Did you know there is…

1 year ago

Navigating the Future of Physician Practice Management – Key 2025 Trends From Black Book Surveys

TAMPA, FLORIDA / ACCESSWIRE / January 10, 2025 / As the medical industry adapts to rapid regulatory changes, operational challenges,…

1 year ago

NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma

BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology,…

1 year ago

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

Preliminary unaudited fourth quarter 2024 net revenue expected to be approximately $12 million to $12.3 million, representing 99% growth over…

1 year ago

NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities

-- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025; expected to support global regulatory filings for…

1 year ago